CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
14.39
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026346 %
Charges from full value of position ($-5.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026346%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004124 %
Charges from full value of position ($0.78)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Sabra Health Care REIT Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 14.39
Open* 14.35
1-Year Change* 9.96%
Day's Range* 14.23 - 14.46
52 wk Range 10.08-14.82
Average Volume (10 days) 2.50M
Average Volume (3 months) 56.63M
Market Cap 3.35B
P/E Ratio -100.00K
Shares Outstanding 231.22M
Revenue 649.10M
EPS -0.38
Dividend (Yield %) 8.29302
Beta 1.24
Next Earnings Date Feb 19, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 5, 2023 14.39 -0.02 -0.14% 14.41 14.47 14.22
Dec 4, 2023 14.39 -0.13 -0.90% 14.52 14.55 14.23
Dec 1, 2023 14.63 0.16 1.11% 14.47 14.76 14.40
Nov 30, 2023 14.57 0.18 1.25% 14.39 14.60 14.32
Nov 29, 2023 14.37 -0.18 -1.24% 14.55 14.59 14.32
Nov 28, 2023 14.48 0.04 0.28% 14.44 14.56 14.27
Nov 27, 2023 14.45 0.05 0.35% 14.40 14.51 14.35
Nov 24, 2023 14.48 0.15 1.05% 14.33 14.54 14.33
Nov 22, 2023 14.39 -0.20 -1.37% 14.59 14.65 14.33
Nov 21, 2023 14.43 0.00 0.00% 14.43 14.58 14.30
Nov 20, 2023 14.54 0.36 2.54% 14.18 14.55 14.16
Nov 17, 2023 14.27 -0.01 -0.07% 14.28 14.36 14.13
Nov 16, 2023 14.19 0.06 0.42% 14.13 14.30 14.07
Nov 15, 2023 14.43 -0.06 -0.41% 14.49 14.78 14.37
Nov 14, 2023 14.51 0.18 1.26% 14.33 14.65 14.30
Nov 13, 2023 14.14 0.17 1.22% 13.97 14.25 13.94
Nov 10, 2023 14.10 0.49 3.60% 13.61 14.13 13.58
Nov 9, 2023 13.61 -0.23 -1.66% 13.84 13.92 13.56
Nov 8, 2023 13.81 -0.07 -0.50% 13.88 13.97 13.59
Nov 7, 2023 13.92 0.33 2.43% 13.59 14.12 13.37

Sabra Events

Time (UTC) Country Event
Monday, February 19, 2024

Time (UTC)

10:59

Country

US

Event

Q4 2023 Sabra Health Care REIT Inc Earnings Release
Q4 2023 Sabra Health Care REIT Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 624.711 569.045 596.769 594.836 623.409
Revenue 624.711 569.045 596.769 594.836 623.409
Cost of Revenue, Total 142.99 117.48 106.663 86.257 49.546
Gross Profit 481.721 451.565 490.106 508.579 573.863
Total Operating Expense 587.434 501.049 449.258 520.014 468.53
Selling/General/Admin. Expenses, Total 39.715 38.304 34.127 31.7 75.533
Depreciation / Amortization 187.782 178.991 176.737 181.549 191.379
Interest Expense (Income) - Net Operating 105.471 98.632 100.424 126.61 147.106
Unusual Expense (Income) 91.853 47.421 10.717 71.683 4.966
Operating Income 37.277 67.996 147.511 74.822 154.879
Gain (Loss) on Sale of Assets -12.011 12.301 2.861 2.3 128.198
Other, Net -3.597 0.373 1.854 2.094 4.48
Net Income Before Taxes -76.363 -111.411 139.127 72.42 282.126
Net Income After Taxes -77.605 -113.256 138.417 69.018 279.115
Minority Interest 0 0 -0.022 -0.033
Net Income Before Extra. Items -77.605 -113.256 138.417 68.996 279.082
Net Income -77.605 -113.256 138.417 68.996 279.082
Total Adjustments to Net Income 0 0 -9.768
Income Available to Common Excl. Extra. Items -77.605 -113.256 138.417 68.996 269.314
Income Available to Common Incl. Extra. Items -77.605 -113.256 138.417 68.996 269.314
Diluted Net Income -77.605 -113.256 138.417 68.996 269.314
Diluted Weighted Average Shares 230.948 219.073 207.253 188.127 178.722
Diluted EPS Excluding Extraordinary Items -0.33603 -0.51698 0.66787 0.36675 1.50689
Dividends per Share - Common Stock Primary Issue 1.52854 1.2 1.35 1.8 1.8
Diluted Normalized EPS -0.0437 -0.41278 0.70558 0.71824 0.82473
Other Operating Expenses, Total 19.623 20.221 20.59 22.215
Interest Income (Expense), Net Non-Operating -98.032 -192.081 -13.099 -6.796 -5.431
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 161.166 161.324 164.985 140.764 155.957
Revenue 161.166 161.324 164.985 140.764 155.957
Cost of Revenue, Total 43.964 43.637 39.155 36.705 34.026
Gross Profit 117.202 117.687 125.83 104.059 121.931
Total Operating Expense 131.166 148.071 153.866 186.779 129.704
Selling/General/Admin. Expenses, Total 9.961 10.294 11.006 9.459 8.379
Depreciation / Amortization 44.142 52.827 49.927 47.427 45.172
Interest Expense (Income) - Net Operating 28.328 28.54 27.898 27.071 25.53
Unusual Expense (Income) 0 8.605 21.24 60.997 11.745
Other Operating Expenses, Total 4.771 4.168 4.64 5.12 4.852
Operating Income 30 13.253 11.119 -46.015 26.253
Interest Income (Expense), Net Non-Operating -0.653 -0.838 -88.317 -4.384 -2.529
Gain (Loss) on Sale of Assets -7.833 -21.515 -7.43 -0.08 -4.501
Other, Net 0.341 -0.196 0.994 -2.163
Net Income Before Taxes 21.514 -8.759 -84.824 -49.485 17.06
Net Income After Taxes 21.188 -9.487 -84.948 -50.064 16.805
Net Income Before Extra. Items 21.188 -9.487 -84.948 -50.064 16.805
Net Income 21.188 -9.487 -84.948 -50.064 16.805
Income Available to Common Excl. Extra. Items 21.188 -9.487 -84.948 -50.064 16.805
Income Available to Common Incl. Extra. Items 21.188 -9.487 -84.948 -50.064 16.805
Diluted Net Income 21.188 -9.487 -84.948 -50.064 16.805
Diluted Weighted Average Shares 232.245 231.165 230.983 230.982 231.682
Diluted EPS Excluding Extraordinary Items 0.09123 -0.04104 -0.36777 -0.21674 0.07253
Dividends per Share - Common Stock Primary Issue 0.3 0.3 0.38146 0.38146 0.38146
Diluted Normalized EPS 0.12445 0.04365 -0.28709 -0.04487 0.14161
Minority Interest
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Cash and Short Term Investments 49.308 111.996 59.076 39.097 50.23
Cash & Equivalents 49.308 111.996 59.076 39.097 50.23
Prepaid Expenses
Total Assets 5747.67 5966.71 5985.6 6069.3 6665.3
Property/Plant/Equipment, Total - Net 4959.34 5162.88 5285.04 5350.67 5853.54
Property/Plant/Equipment, Total - Gross 5872.69 5994.21 5966.69 5880.58 6255.88
Accumulated Depreciation, Total -913.345 -831.324 -681.657 -539.213 -402.338
Note Receivable - Long Term 360.325 342.031 58.899 63.07 69.46
Other Long Term Assets, Total 4.624 3.89 6.447 10.046 9.428
Payable/Accrued 124.059 121.489 130.176 98.366 90.298
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 2691.28 2587.18 2576.38 2580.84 3414.89
Total Long Term Debt 2506.77 2394.48 2372.37 2402.1 3232
Long Term Debt 2506.77 2394.48 2372.37 2402.1 3232
Minority Interest 0 4.333
Total Equity 3056.4 3379.53 3409.23 3488.46 3250.41
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2.31 2.304 2.106 2.052 1.783
Additional Paid-In Capital 4486.97 4482.45 4163.23 4072.08 3507.93
Retained Earnings (Accumulated Deficit) -1451.94 -1095.2 -716.195 -573.283 -271.595
Other Equity, Total 19.063 -10.021 -39.911 -12.388 12.301
Total Liabilities & Shareholders’ Equity 5747.67 5966.71 5985.6 6069.3 6665.3
Total Common Shares Outstanding 231.009 230.399 210.561 205.208 178.307
Total Preferred Shares Outstanding
Total Receivables, Net 147.908 138.108 160.646 133.666 137.817
Intangibles, Net 40.131 54.063 82.796 101.509 131.097
Other Assets, Total 7.477 29.344
Other Liabilities, Total 42.244 49.713 57.725 70.572 88.255
Long Term Investments 186.033 153.735 332.701 363.764 384.382
Accrued Expenses 18.2 21.5 16.1 9.8
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Cash and Short Term Investments 33.256 27.234 33.532 49.308 26.289
Cash & Equivalents 33.256 27.234 33.532 49.308 26.289
Total Receivables, Net 152.239 146.641 132.736 147.908 148.674
Total Assets 5380.56 5524.33 5556.31 5747.67 5844.92
Property/Plant/Equipment, Total - Net 4603.01 4751.9 4797.04 4959.34 5018.9
Property/Plant/Equipment, Total - Gross 5605.5 5744.12 5749.83 5872.69 5901.66
Accumulated Depreciation, Total -1002.48 -992.222 -952.791 -913.345 -882.755
Intangibles, Net 32.749 35.99 39.369 40.131 48.299
Long Term Investments 192.676 196.137 192.116 186.033 256.358
Note Receivable - Long Term 361.026 361.284 356.365 360.325 341.533
Other Long Term Assets, Total 5.602 5.146 5.152 4.624 4.859
Payable/Accrued 106.939 105.465 121.602 124.059 123.217
Accrued Expenses 21.1 16.4 21.4 18.2 22
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 2511.71 2580.59 2580.08 2691.28 2636.18
Total Long Term Debt 2349.48 2420.04 2396.62 2506.77 2446.94
Long Term Debt 2349.48 2420.04 2396.62 2506.77 2446.94
Other Liabilities, Total 34.192 38.685 40.464 42.244 44.023
Total Equity 2868.85 2943.74 2976.23 3056.4 3208.73
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2.312 2.312 2.312 2.31 2.31
Additional Paid-In Capital 4491.92 4489.11 4487.71 4486.97 4484.77
Retained Earnings (Accumulated Deficit) -1665.05 -1579.91 -1531.23 -1451.94 -1296.87
Other Equity, Total 39.669 32.239 17.438 19.063 18.522
Total Liabilities & Shareholders’ Equity 5380.56 5524.33 5556.31 5747.67 5844.92
Total Common Shares Outstanding 231.22 231.219 231.195 231.009 230.977
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -77.605 -113.256 138.417 69.018 279.115
Cash From Operating Activities 315.733 356.39 354.852 372.475 360.586
Cash From Operating Activities 187.782 178.991 176.737 181.549 191.379
Non-Cash Items 225.249 267.953 42.438 145.417 -91.41
Cash Taxes Paid 1.657 1.839 2.439 3.911 1.8
Cash Interest Paid 97.723 85.464 92.589 123.854 137.668
Changes in Working Capital -19.693 22.702 -2.74 -23.509 -18.498
Cash From Investing Activities -216.248 -336.196 -136.451 262.844 -258.494
Capital Expenditures -92.204 -99.448 -92.945 -51.136 -261.511
Other Investing Cash Flow Items, Total -124.044 -236.748 -43.506 313.98 3.017
Cash From Financing Activities -161.707 30.14 -202.109 -646.18 -629.344
Financing Cash Flow Items -0.02 -39.513 -0.83 -26.416 -2.537
Total Cash Dividends Paid -277.157 -262.919 -278.299 -335.435 -325.22
Issuance (Retirement) of Stock, Net -7.31 308.713 80.092 549.328 -144.249
Issuance (Retirement) of Debt, Net 122.78 23.859 -3.072 -833.657 -157.338
Foreign Exchange Effects 0.268 0.029 0.088 0.346 -0.539
Net Change in Cash -61.954 50.363 16.38 -10.515 -527.791
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -9.487 -77.605 7.343 57.407 40.602
Cash From Operating Activities 68.289 315.733 248.146 139.683 63.114
Cash From Operating Activities 52.827 187.782 137.855 90.428 45.256
Non-Cash Items 33.57 225.249 106.418 23.817 3.681
Cash Interest Paid 22.318 97.723 68.778 49.968 18.383
Changes in Working Capital -8.621 -19.693 -3.47 -31.969 -26.425
Cash From Investing Activities 113.175 -216.248 -185.088 -128.099 -37.242
Capital Expenditures -39.63 -92.204 -83.985 -20.573 -20.573
Other Investing Cash Flow Items, Total 152.805 -124.044 -101.103 -107.526 -16.669
Cash From Financing Activities -196.071 -161.707 -148.188 -56.568 -112.519
Financing Cash Flow Items -18.127 -0.02 -0.006 -0.006 -0.006
Total Cash Dividends Paid -69.351 -277.157 -207.861 -138.565 -69.275
Issuance (Retirement) of Stock, Net -1.847 -7.31 -6.894 -3.803 -3.748
Issuance (Retirement) of Debt, Net -106.746 122.78 66.573 85.806 -39.49
Foreign Exchange Effects -0.641 0.268 0.392 0.619 0.04
Net Change in Cash -15.248 -61.954 -84.738 -44.365 -86.607
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 14.7458 34095077 -1206089 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 12.2034 28216475 131971 2023-06-30 LOW
Principal Global Investors (Equity) Investment Advisor 8.9481 20689676 5041116 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.3256 12313674 -150668 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.3329 5394150 182421 2023-06-30 LOW
LSV Asset Management Investment Advisor 1.8343 4241249 -163500 2023-06-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 1.7212 3979839 18926 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.4037 3245608 57679 2023-06-30 LOW
CenterSquare Investment Management LLC. Investment Advisor 1.1849 2739622 -2053648 2023-06-30 LOW
LaSalle Investment Management Securities, LLC Investment Advisor 1.1652 2694134 -114412 2023-06-30 LOW
Weiss Multi-Strategy Advisers LLC Hedge Fund 1.1629 2688777 110424 2023-06-30 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 1.1262 2603908 -39831 2023-06-30 LOW
Victory Capital Management Inc. Investment Advisor/Hedge Fund 0.9553 2208786 78407 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9328 2156781 -400682 2022-12-31 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 0.8419 1946553 -53003 2023-09-30 LOW
Systematic Financial Management, L.P. Investment Advisor 0.7896 1825737 -19191 2023-06-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7792 1801668 45806 2023-06-30 LOW
Advisors Capital Management, LLC Investment Advisor 0.7743 1790432 32503 2023-06-30 LOW
DWS Investments UK Limited Investment Advisor 0.7514 1737405 -1217937 2023-06-30 LOW
Adelante Capital Management LLC Investment Advisor 0.7275 1682193 965237 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sabra Company profile

About Sabra Health Care REIT Inc

Sabra Health Care REIT, Inc. is a self-administered, self-managed real estate investment trust (REIT). The Company through its subsidiaries, owns and invests in real estate serving the healthcare industry. Its primary business consists of acquiring, financing, and owning real estate property to be leased to third-party tenants in the healthcare sector. It is engaged in leasing properties to tenants and owning properties operated by third-party property managers throughout the United States and Canada. The Company’s investment portfolio comprises of skilled nursing/transitional care facilities, senior housing communities and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements; investments in loans receivable; and preferred equity investments.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Sabra Health Care REIT Inc revenues decreased 5% to $569M. Net loss totaled $113.3M vs. income of $138.4M. Revenues reflect NAREIT FFO - Per Share - Diluted - Total decrease of 31% to $1.15, Fixed Charge Coverage Ratio, Total decrease of 2% to 5.03, Rental and related revenues decrease of 8% to $396.7M.

Equity composition

Common Stock $0.01 Par, 4/11, 125B auth., 25,0092,591 issd. Insiders own 1%.

Industry: Healthcare REITs

Suite 550
18500 Von Karman
IRVINE
CALIFORNIA 92612
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

US100

15,935.50 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

71.78 Price
-0.690% 1D Chg, %
Long position overnight fee -0.0227%
Short position overnight fee 0.0007%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

44,269.90 Price
+0.770% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,022.62 Price
+0.170% 1D Chg, %
Long position overnight fee -0.0197%
Short position overnight fee 0.0115%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading